| Literature DB >> 25136143 |
Camila Bosquiero Papini1, Priscila M Nakamura1, Lucas P Zorzetto1, Janice L Thompson2, Anna C Phillips2, Eduardo Kokubun1.
Abstract
The aim of this study was to analyze the impact of a community-based exercise program in primary care on inflammatory biomarkers and hormone levels. The 1-year quasiexperimental study involved 13 women (mean age = 56.8 ± 11.4 years) and it was developed in two basic health care units in Rio Claro City, Brazil. The physical exercise intervention was comprised of two, 60-minute sessions/week. The inflammatory biomarkers were measured at baseline, 6 months, and 1 year. Repeated measures ANOVA analyses indicated that the intervention was effective in reducing CRP and TNFα after 1 year compared to baseline and 6 months (P < 0.05). There were no changes in IL10, IL6, and insulin after 1 year. However, leptin significantly increased at 1 year (P = 0.016). The major finding of this study is that a community-based exercise program can result in a decrease or maintenance of inflammatory biomarkers after 1 year, and thus has the potential to be a viable public health approach for chronic disease prevention.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25136143 PMCID: PMC4127245 DOI: 10.1155/2014/185707
Source DB: PubMed Journal: Mediators Inflamm ISSN: 0962-9351 Impact factor: 4.711
Figure 1Recruitment of participants for the study. Evaluations were done at baseline, 6 months, and 1 year of SARC intervention.
Anthropometric characteristics (mean, standard deviation) of participants at baseline, after 6 months, and after 1 year of exercise intervention.
| Baseline | 6 months | 1 year |
|
|
| |
|---|---|---|---|---|---|---|
| Weight (kg) | 67.3 ± 11.5 | 66.8 ± 11.4 | 67.2 ± 10.9 | 0.541 | 0.631 | 1.000 |
| BMI (kg/m2) | 27.5 ± 5.6 | 26.8 ± 6.0 | 27.9 ± 5.6 | 0.500 | 0.316 | 1.000 |
| WHR | 0.88 ± 0.8 | 0.86 ± 0.8 | 0.89 ± 0.7 | 0.863 | 0.326 | 1.000 |
BL: baseline; 6 M: 6 months; 1 Y: 1 year; BMI: body mass index; WHR: waist and hip ratio.
Inflammatory biomarkers and hormone concentration levels (mean, standard deviation) at baseline, after 6 months, and after 1 year of exercise intervention.
| Biomarker | BL | 6 M | 1 Y |
|
|
|
|---|---|---|---|---|---|---|
| CRP (mg | 3.4 ± 1.2 | 3.0 ± 1.2 | 1.5 ± 1.0∗ | 0.999 | 0.001 | 0.003 |
| IL10 (pg | 4.8 ± 2.0 | 4.4 ± 2.3 | 4.2 ± 1.5 | 0.988 | 0.681 | 0.602 |
| IL6 (pg | 4.4 ± 1.1 | 4.2 ± 1.5 | 3.4 ± 0.7 | 0.999 | 0.236 | 0.163 |
| TNF | 10.6 ± 5.6 | 7.6 ± 4.0 | 5.6 ± 3.0∗ | 0.082 | 0.001 | 0.004 |
| Leptin (ng/mL−1) | 2.69 ± 2.25 | 2.30 ± 1.66 | 7.60 ± 4.89∗ | 0.999 | 0.016 | 0.003 |
| Insulin (ng/mL−1) | 1.09 ± 1.01 | 0.83 ± 0.41 | 0.67 ± 0.17 | 0.898 | 0.405 | 0.642 |
| IL10/TNF | 0.59 ± 0.4 | 0.64 ± 0.2 | 0.85 ± 0.3 | — | — | — |
BL: baseline; 6 M: 6 months; 1 Y: 1 year; CRP: C-reactive protein; IL10: interleukin 10; IL6: interleukin 6; TNFα: tumor necrosis factor alpha.
∗Statistically significant difference from baseline.
Statistically significant difference after 6 months.
Figure 2Levels of C-reactive protein (CRP), interleukin 10 (IL10), interleukin 6 (IL6), tumor necrosis factor alpha (TNFα), leptin, and insulin at baseline, after 6 months, and after 1 year of exercise intervention. *Statistically significant difference from baseline. Statistically significant difference from 6 months.